Rare diseases
Investigational molecules
Locations
Study of JNJ-68284528 for Treating Multiple Myeloma in Patients Using Ciltacabtagene Autoleucel and Drug Combination
SpainStudy on the Effectiveness and Safety of CYP-001 and Corticosteroids for Adults with High-Risk Acute Graft Versus Host Disease
SpainStudy on the Effects of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) in Patients with Progressive Supranuclear Palsy
SpainStudy on Durvalumab and Chemotherapy for Patients with Advanced Biliary Tract Cancer
SpainStudy on the Safety and Effects of GEN1055 Alone and with Pembrolizumab for Patients with Malignant Solid Tumors
SpainStudy of Relatlimab, Nivolumab, and Drug Combination for Patients with Advanced Cancer
SpainStudy of Pembrolizumab, Lenvatinib, and Chemotherapy for First-Line Treatment in Extensive-Stage Small Cell Lung Cancer Patients
SpainStudy of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors
SpainStudy Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma
SpainStudy of DF6002 alone and combined with nivolumab in patients with advanced solid tumors: A safety and effectiveness trial
SpainStudy of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy
SpainStudy of Azenosertib (ZN-c3) for Women with Recurrent or Persistent Uterine Serous Carcinoma
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
